Free Trial
OTCMKTS:OXBDF

Oxford Biomedica (OXBDF) Stock Price, News & Analysis

Oxford Biomedica logo
$5.20 -0.21 (-3.88%)
(As of 11/22/2024 ET)

About Oxford Biomedica Stock (OTCMKTS:OXBDF)

Key Stats

Today's Range
$5.20
$5.33
50-Day Range
$4.21
$5.68
52-Week Range
$2.09
$5.68
Volume
1,054 shs
Average Volume
962 shs
Market Capitalization
$520.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, and adenoviral vectors. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.

Receive OXBDF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter.

OXBDF Stock News Headlines

Oxford Biomedica Aligns Executive Incentives with Goals
Oxford Biomedica price target raised to 450 GBp from 305 GBp at JPMorgan
JD Vance Predicts: Wall Street vs. Trump & Your Money
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
Oxford Biomedica Seeks Stock Market Expansion
RBC Capital Sticks to Its Buy Rating for Oxford BioMedica (OXBDF)
See More Headlines

OXBDF Stock Analysis - Frequently Asked Questions

Oxford Biomedica's stock was trading at $2.69 on January 1st, 2024. Since then, OXBDF shares have increased by 93.3% and is now trading at $5.20.
View the best growth stocks for 2024 here
.

Shares of OXBDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Today
11/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:OXBDF
Previous Symbol
NASDAQ:OXBDF
CIK
N/A
Fax
N/A
Employees
891
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$111.34 million
Book Value
$1.01 per share

Miscellaneous

Free Float
N/A
Market Cap
$520.83 million
Optionable
Not Optionable
Beta
1.22
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (OTCMKTS:OXBDF) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners